Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Early Restrictive Fluid Strategy Didn’t Lower Mortality for Sepsis-induced Hypotension

Dr. Klein

Dr. Klein

Clinical question: Does a restrictive fluid strategy within the first 24 hours improve all-cause mortality among patients with sepsis-induced hypotension?

Background: There are limited data to guide the specific use of intravenous (IV) fluids or vasopressors in the early resuscitation of patients with sepsis-induced hypotension. Previous observational data suggested that a restrictive fluid strategy that prioritized vasopressors was potentially superior to a liberal fluid strategy. However, a recent, randomized, clinical trial in patients already admitted to the intensive care unit (ICU) showed no difference in 90-day mortality when comparing a restrictive fluid approach to unguided resuscitation.

Study design: Multicenter, randomized, unblinded, superiority trial

Setting: 60 medical centers in the U.S.

Synopsis: A total of 1,563 adult patients with suspected or confirmed sepsis-induced hypotension after administration of 1 to 3 L of IV fluid were randomized in a 1:1 ratio to either a restrictive or liberal fluid strategy protocol for a 24-hour period. The restrictive fluid protocol prioritized vasopressors. The liberal fluid protocol recommended an additional 2 L of IV fluid, followed by further boluses based on clinical triggers. Rescue fluids or vasopressors were permitted in both groups for specific parameters. Key exclusion criteria were receipt of more than 3 L of IV fluid by emergency medicine services and the presence of fluid overload.

There was no statistically significant difference in all-cause mortality before discharge by day 90 between the restrictive and liberal fluid groups (14% versus 14.9%, respectively; P=0.61). Limitations include lack of blinding, generalizability to patients with extremes of volume overload or depletion, and generalizability to patients with delayed recognition of sepsis-induced hypotension or who are in the later phases of care. These results were similar to a previous study in patients already admitted to an ICU.

Bottom line: For patients with sepsis-induced hypotension refractory to initial treatment with 1 to 3 L of IV fluid, a restrictive fluid strategy implemented within the first 24 hours did not result in significantly higher or lower mortality before discharge by day 90.

Citation: National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network, et al. Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med. 2023;388(6):499-510.

Dr. Klein is a hospital medicine attending physician at Maine Medicine Center, Portland, Maine, and an assistant professor at Tufts University School of Medicine, Boston.

  • Early Restrictive Fluid Strategy Didn’t Lower Mortality for Sepsis-induced Hypotension

    September 1, 2023

  • Sustained Reduction in Lab Ordering After Implementing Mindful Ordering Initiatives

    September 1, 2023

  • Prioritizing Discharging Patients While Rounding Didn’t Result in Earlier Discharge Times or Reduced LOS

    September 1, 2023

  • Real-world Application of Oral Therapy for Infective Endocarditis

    September 1, 2023

  • ODS in Hospitalized Patients with Hyponatremia

    September 1, 2023

  • Acetazolamide in Acute Decompensated Heart Failure With Volume Overload

    September 1, 2023

  • Postsurgical Delirium Predicts Long-term Cognitive Decline

    September 1, 2023

  • CT for Evaluation of Acute Abdominal Pain is Less Accurate Without Contrast

    September 1, 2023

  • Consider Platelet Transfusion Prior to CVC Placement for Patients with High-risk Thrombocytopenia

    September 1, 2023

  • Summary of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Report

    September 1, 2023

1 … 43 44 45 46 47 … 964
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences